Type 2 Diabetes Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- People aged 18 years or older.
- People who are permanent residents of Dali City and have lived there for at least six consecutive months in a row.
- People who are registered as rural residents.
- People with no known history of diabetes.
- People who meet at least one high-risk factor for type 2 diabetes as defined in the Chinese Guidelines for the Prevention and Treatment of Diabetes (confirm with trial site for the full list of risk factors).
- People who are able to understand the study information and sign a written consent form.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People with a known history of type 2 diabetes, or who are currently taking any medication to lower blood sugar.
- People who have had an HbA1c blood test (a measure of average blood sugar levels) with a clear result in the past three months, or who have completed a standardised diabetes screening programme in the past six months.
- People who are pregnant or breastfeeding at the time of joining the trial.
- People who have an active thyroid condition or another active hormonal disorder, such as Cushing's syndrome or acromegaly, at the time of joining.
- People with a known blood disorder affecting haemoglobin, severe anaemia, recent significant blood loss, or who have had a blood transfusion or donated blood in the past three months.
- People who are currently receiving treatments that could significantly affect how HbA1c test results are interpreted, such as erythropoietin therapy or a recent course of high-dose iron treatment.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: William Chi Wai Wong, MD, The University of Hong Kong
Phone: 852-25185656
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Detection rate of T2DM
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.